APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 213 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,603,010 | -92.3% | 31,000 | -93.3% | 0.00% | -91.7% |
| Q2 2022 | $20,801,000 | +26.0% | 460,000 | +41.5% | 0.05% | +54.8% |
| Q1 2022 | $16,513,000 | +439.3% | 325,000 | +225.0% | 0.03% | +287.5% |
| Q4 2019 | $3,062,000 | -74.6% | 100,000 | -80.0% | 0.01% | -73.3% |
| Q3 2019 | $12,045,000 | -4.9% | 500,000 | 0.0% | 0.03% | -6.2% |
| Q2 2019 | $12,670,000 | +29.9% | 500,000 | 0.0% | 0.03% | +33.3% |
| Q1 2019 | $9,750,000 | +47.8% | 500,000 | 0.0% | 0.02% | +33.3% |
| Q4 2018 | $6,595,000 | +69.4% | 500,000 | +128.3% | 0.02% | +100.0% |
| Q3 2018 | $3,894,000 | -37.0% | 219,000 | -22.1% | 0.01% | -35.7% |
| Q2 2018 | $6,182,000 | – | 281,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |